{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:25:45Z","timestamp":1791221145704,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jaut.2010.06.021","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T05:45:35Z","timestamp":1283319935000},"page":"299-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener\u2019s autoantigen"],"prefix":"10.1016","volume":"35","author":[{"given":"Francisco","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber M.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter E.","family":"Jenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2010.06.021_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","article-title":"Anticytoplasmic autoantibodies: their immunodiagnostic value","volume":"111","author":"N\u00f6lle","year":"1989","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jaut.2010.06.021_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/346520a0","article-title":"Wegener\u2019s autoantigen decoded","volume":"346","author":"Jenne","year":"1990","journal-title":"Nature"},{"issue":"643","key":"10.1016\/j.jaut.2010.06.021_bib3","first-page":"e9","article-title":"ANCA are detectable in nearly all patients with active severe Wegener\u2019s granulomatosis","volume":"120","author":"Finkielman","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jaut.2010.06.021_bib4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","article-title":"Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease","volume":"126","author":"Merkel","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2010.06.021_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR Project for ANCA Assay Standardization [see comments]","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaut.2010.06.021_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.2001.5200","article-title":"Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions","volume":"103","author":"Russell","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib7","first-page":"S7","article-title":"Antineutrophil cytoplasmic antibodies: are they pathogenic?","volume":"22","author":"Specks","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2010.06.021_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2007.11.005","article-title":"Pathogenesis of PR3-ANCA associated vasculitis","volume":"30","author":"Kallenberg","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2010.06.021_bib9","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener\u2019s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels. A prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2010.06.021_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2010.06.021_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener\u2019s granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2010.06.021_bib12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2010.06.021_bib13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/ard.2006.064626","article-title":"Rats and mice immunised with chimeric human\/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes","volume":"66","author":"van der Geld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2010.06.021_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002281-200201000-00004","article-title":"New findings in pathogenesis of antineutrophil cytoplasm antibody- associated vasculitis","volume":"14","author":"Savage","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2010.06.021_bib15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1681\/ASN.2005101048","article-title":"Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies","volume":"17","author":"Jennette","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaut.2010.06.021_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/ar99","article-title":"What you should know about PR3-ANCA: conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA","volume":"2","author":"Specks","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jaut.2010.06.021_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","article-title":"Proteinase 3, Wegener\u2019s autoantigen: from gene to antigen","volume":"69","author":"van der Geld","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaut.2010.06.021_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biochi.2007.10.009","article-title":"Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions","volume":"90","author":"Korkmaz","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.jaut.2010.06.021_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2249.1992.tb05860.x","article-title":"Interference of Wegener\u2019s granulomatosis autoantibodies with neutrophil Proteinase 3 activity","volume":"90","author":"van de Wiel","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.1993.tb08192.x","article-title":"Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-a1-antitrypsin complexation to disease activity in Wegener\u2019s granulomatosis","volume":"93","author":"Dolman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib21","first-page":"249","article-title":"Characterization of monoclonal antibodies to proteinase 3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies","volume":"3","author":"Sommarin","year":"1995","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.jaut.2010.06.021_bib22","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ki.1995.216","article-title":"Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener\u2019s granulomatosis","volume":"47","author":"Daouk","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaut.2010.06.021_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01926.x","article-title":"Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener\u2019s granulomatosis","volume":"129","author":"van der Geld","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4049\/jimmunol.149.4.1409","article-title":"Antineutrophil cytoplasmic autoantibodies in Wegener\u2019s granulomatosis recognize conformational epitopes on proteinase 3","volume":"149","author":"Bini","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib25","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.4049\/jimmunol.152.9.4722","article-title":"Epitopes on proteinase-3 recognized by antibodies from patients with Wegener\u2019s granulomatosis","volume":"152","author":"Williams","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2249.1995.tb06644.x","article-title":"Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies","volume":"102","author":"Chang","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2249.2001.01420.x","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site","volume":"123","author":"Griffith","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib28","first-page":"1113","article-title":"Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener\u2019s granulomatosis","volume":"137","author":"Csernok","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2010.06.021_bib29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","article-title":"Wegener\u2019s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils","volume":"84","author":"Goldschmeding","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2010.06.021_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2249.1999.01079.x","article-title":"Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies","volume":"118","author":"van der Geld","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(97)00203-2","article-title":"Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA\/PR3 immunecomplexes","volume":"211","author":"Sun","year":"1998","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaut.2010.06.021_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2005.07.011","article-title":"A novel binding assay to assess specificity of monoclonal antibodies","volume":"305","author":"Warren","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaut.2010.06.021_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1523-1755.2003.00765.x","article-title":"Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA","volume":"63","author":"Capizzi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaut.2010.06.021_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-5793(96)00669-2","article-title":"Recombinant human proteinase 3, the Wegener\u2019s autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA","volume":"390","author":"Specks","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2010.06.021_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2249.1998.00730.x","article-title":"A proportion of proteinase 3-specific anti-neutrophil cytoplasmic antibodies only react with proteinase 3 after cleavage of its N-terminal activation dipeptide","volume":"114","author":"Sun","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib36","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1016\/j.febslet.2005.08.056","article-title":"Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments","volume":"579","author":"Wiesner","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2010.06.021_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(97)00418-3","article-title":"Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis","volume":"408","author":"Jenne","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2010.06.021_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jmbi.1996.0458","article-title":"The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener\u2019s granulomatosis antibodies","volume":"261","author":"Fujinaga","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jaut.2010.06.021_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-2249.1997.4561353.x","article-title":"Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"109","author":"Specks","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2005.09.004","article-title":"A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases","volume":"307","author":"Lee","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaut.2010.06.021_bib41","first-page":"S45","article-title":"Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener\u2019s granulomatosis","volume":"27","author":"Finkielman","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2010.06.021_bib42","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2010.06.021_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: the proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 1","key":"10.1016\/j.jaut.2010.06.021_bib44","article-title":"Monoclonal antibodies directed against proteinase 3 as tools for epitope mapping of c-ANCA positive sera (abstract)","volume":"112","author":"van der Geld","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib45","first-page":"A959","article-title":"Recombinant human-murine chimaeric proteinase 3 (PR3) molecules as tools for PR3-ANCA epitope mapping","volume":"13","author":"Specks","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jaut.2010.06.021_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2004.02314.x","article-title":"Epitope mapping of anti-PR3 antibodies using chimeric human\/mouse PR3 recombinant proteins","volume":"135","author":"Selga","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4049\/jimmunol.0903887","article-title":"Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener\u2019s granulomatosis","volume":"185","author":"Kuhl","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2249.1995.tb05577.x","article-title":"Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?","volume":"99","author":"Baslund","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2249.2006.03179.x","article-title":"Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma","volume":"146","author":"Lee","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2010.06.021_bib50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/art.23469","article-title":"Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions","volume":"58","author":"Peikert","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2010.06.021_bib51","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/prot.21853","article-title":"Computational prediction of the binding site of proteinase 3 to the plasma membrane","volume":"71","author":"Hajjar","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.jaut.2010.06.021_bib52","doi-asserted-by":"crossref","first-page":"35976","DOI":"10.1074\/jbc.M806754200","article-title":"A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors","volume":"283","author":"Korkmaz","year":"2008","journal-title":"J Biol Chem"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841110000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841110000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:02:58Z","timestamp":1760256178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841110000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0896841110000855"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2010.06.021","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener\u2019s autoantigen","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2010.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}